"BCG Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.
| Descriptor ID |
D001500
|
| MeSH Number(s) |
D20.215.894.135.825.100
|
| Concept/Terms |
BCG Vaccine- BCG Vaccine
- Vaccine, BCG
- Bacillus Calmette Guerin Vaccine
- Calmette Guerin Bacillus Vaccine
- Calmette's Vaccine
- Calmette Vaccine
- Calmettes Vaccine
- Vaccine, Calmette's
|
Below are MeSH descriptors whose meaning is more general than "BCG Vaccine".
Below are MeSH descriptors whose meaning is more specific than "BCG Vaccine".
This graph shows the total number of publications written about "BCG Vaccine" by people in this website by year, and whether "BCG Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 3 | 0 | 3 |
| 1992 | 1 | 0 | 1 |
| 1995 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 2001 | 2 | 1 | 3 |
| 2002 | 3 | 0 | 3 |
| 2003 | 3 | 0 | 3 |
| 2004 | 3 | 2 | 5 |
| 2005 | 3 | 5 | 8 |
| 2006 | 2 | 2 | 4 |
| 2007 | 6 | 3 | 9 |
| 2008 | 6 | 5 | 11 |
| 2009 | 5 | 1 | 6 |
| 2010 | 1 | 4 | 5 |
| 2011 | 1 | 1 | 2 |
| 2012 | 4 | 2 | 6 |
| 2013 | 7 | 2 | 9 |
| 2014 | 3 | 2 | 5 |
| 2015 | 7 | 2 | 9 |
| 2016 | 2 | 6 | 8 |
| 2017 | 2 | 3 | 5 |
| 2018 | 7 | 5 | 12 |
| 2019 | 3 | 0 | 3 |
| 2020 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "BCG Vaccine" by people in Profiles.
-
Meena J, Yadav A, Kumar J. BCG Vaccination Policy and Protection Against COVID-19. Indian J Pediatr. 2020 09; 87(9):749.
-
O'Connor E, Teh J, Kamat AM, Lawrentschuk N. Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again? Future Oncol. 2020 Jul; 16(19):1323-1325.
-
Hegarty PK, Sfakianos JP, Giannarini G, DiNardo AR, Kamat AM. COVID-19 and Bacillus Calmette-Guérin: What is the Link? Eur Urol Oncol. 2020 06; 3(3):259-261.
-
Konety BR, Narayan VM, Dinney CPN. Bacillus Calmette-Guérin Salvage Therapy: Definitions and Context. Urol Clin North Am. 2020 Feb; 47(1):1-4.
-
Li R, Kamat AM. Predictors of Response to Intravesical Therapy. Urol Clin North Am. 2020 Feb; 47(1):23-33.
-
Liem EIML, Oddens JR, Vernooij RWM, Li R, Kamat A, Dinney CP, Mengual L, Alcaraz A, Izquierdo L, Savic S, Thalmann GN, Bubendorf L, Sylvester RJ, de Reijke TM. The Role of Fluorescence In Situ Hybridization for Predicting Recurrence after Adjuvant bacillus Calmette-Guérin in Patients with Intermediate and High Risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data. J Urol. 2020 02; 203(2):283-291.
-
Foerster B, D'Andrea D, Abufaraj M, Broenimann S, Karakiewicz PI, Rouprêt M, Gontero P, Lerner SP, Shariat SF, Soria F. Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature. Urol Oncol. 2019 07; 37(7):430-436.
-
du Preez K, Seddon JA, Schaaf HS, Hesseling AC, Starke JR, Osman M, Lombard CJ, Solomons R. Global shortages of BCG vaccine and tuberculous meningitis in children. Lancet Glob Health. 2019 01; 7(1):e28-e29.
-
Peyton CC, Chipollini J, Azizi M, Kamat AM, Gilbert SM, Spiess PE. Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what. World J Urol. 2019 Oct; 37(10):2017-2029.
-
Duplisea JJ, Mokkapati S, Plote D, Schluns KS, McConkey DJ, Yla-Herttuala S, Parker NR, Dinney CP. The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside. World J Urol. 2019 Oct; 37(10):2041-2049.